Forma Therapeutics, Inc.
Clinical trials sponsored by Forma Therapeutics, Inc., explained in plain language.
-
Fatty liver drug trial halted early: what we learned
Disease control TerminatedThis early-stage study tested an experimental drug called FT-4101 in 14 overweight or obese adults with NASH, a serious fatty liver disease. The main goals were to check safety and see if the drug could reduce liver fat. The study was stopped early, so results are limited, but it…
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
MDS anemia drug trial halted early – what we know
Disease control TerminatedThis study tested a drug called etavopivat to see if it could improve anemia in adults with a low-risk type of MDS (a bone marrow disorder). The trial was stopped early, and only 17 people took part. The main goal was to see if the drug could raise red blood cell levels or reduce…
Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:12 UTC